Guardant Health (GH) Net Cash Flow (2017 - 2026)
Guardant Health's Net Cash Flow history spans 9 years, with the latest figure at -$199.4 million for Q4 2025.
- On a quarterly basis, Net Cash Flow fell 250.35% to -$199.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$140.8 million, a 71.96% increase, with the full-year FY2025 number at -$140.8 million, up 71.96% from a year prior.
- Net Cash Flow hit -$199.4 million in Q4 2025 for Guardant Health, down from -$45.4 million in the prior quarter.
- Over the last five years, Net Cash Flow for GH hit a ceiling of $675.3 million in Q4 2023 and a floor of -$356.9 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$16.9 million across 5 years, with a median of -$31.6 million in 2022.
- Biggest five-year swings in Net Cash Flow: crashed 614.42% in 2022 and later surged 5365.04% in 2025.
- Tracing GH's Net Cash Flow over 5 years: stood at -$339.9 million in 2021, then soared by 94.76% to -$17.8 million in 2022, then soared by 3892.93% to $675.3 million in 2023, then plummeted by 108.43% to -$56.9 million in 2024, then crashed by 250.35% to -$199.4 million in 2025.
- Business Quant data shows Net Cash Flow for GH at -$199.4 million in Q4 2025, -$45.4 million in Q3 2025, and -$69.3 million in Q2 2025.